Domestic Firm Implements Accounting Change for Expected Sales Return

Youngjin Pharmaceutical announced on February 18th that it has implemented a change in the company's financial accounting standards, in the area of revenue and profit recognitions as related to an expected sales return.

When the sales return is expected under reasonable and foreseeable circumstances, the estimated figures will be generated to make both the revenue and cost deductions. Also,...